Argomed's Series C Round

Argomed raised a round of funding on April 24, 1999.

Company developing a proprietary, water-induced thermotherapy device and technique to address the non-surgical treatment of benign prostatic hyperplasia (BPH). BPH is a condition that afflicts the maj…

Articles about Argomed's Series C Round: